BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 26, 2018
View Archived Issues
FDA grants orphan drug designation to Lin's LBS-007
Read More
Mirati Therapeutics updates progress of key programs
Read More
Ono applies for manufacturing and marketing approval of encorafenib and binimetinib in Japan
Read More
ADC Therapeutics terminates its ADCT-502 program in HER2-expressing solid tumors
Read More
First patient dosed in phase IIb study of chikungunya VLP vaccine
Read More
FDA grants fast track designation to SYNB-1618
Read More
STRIVE trial results show promise for AVXS-101 in spinal muscular atrophy type 1 patients
Read More
FDA accepts for review sBLA for Fluzone Quadrivalent 0.5 mL for younger children
Read More
AbbVie submits BLA to the FDA for risankizumab in moderate to severe plaque psoriasis
Read More
Novel glucose transporter inhibitor SRI-37919 reduces glioblastoma cell growth
Read More
Chugai reviews highlights of first quarter 2018
Read More
Long-term exposure to ZYN-002 improves focal seizure frequency in epilepsy patients
Read More
Entasis Therapeutics and Zai Lab enter strategic development collaboration for ETX-2514
Read More
Phase IIb/III rheumatoid arthritis study of upadacitinib in Japanese patients meets primary endpoint
Read More
European Commission approves new dosing schedules for Opdivo
Read More
Sumitomo Dainippon Pharma, MMV enter joint research agreement
Read More
Phase III results presented for solriamfetol on excessive sleep in narcolepsy patients
Read More
Durect initiates patient dosing in phase IIa study of DUR-928 in alcoholic hepatitis
Read More
Maxinovel Pharmaceuticals presents the discovery of small-molecule PD-1/PD-L1 inhibitors
Read More
FDA grants fast track designation for ORP-101
Read More
Zealand holds end-of-phase II meeting with FDA on glepaglutide for short bowel syndrome
Read More
AveXis initiates phase III SPRINT trial of AVXS-101 in presymptomatic patients with SMA
Read More
Interim phase II results encouraging for tropifexor in primary biliary cirrhosis
Read More
Phase I/II results for DS-5141 in patients with DMD
Read More
